Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 3, 2020BloodOpen Access

Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL

View Full Paper
Ask AI
Bookmark
Share

Authors

NSNeeraj SainiThe University of Texas MD Anderson Cancer CenterDMDavid MarínThe University of Texas MD Anderson Cancer CenterCLCelina LedesmaThe University of Texas MD Anderson Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Saini et al. (2020) studied this question.

synapsesocial.com/papers/6a6f99adac440176ef2842c4https://doi.org/10.1182/blood.2019004685
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome‐positive acute lymphoblastic leukemia2019 · 38 citations
  2. 2Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia2016 · 260 citations
  3. 3Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome–positive leukemia2006 · 226 citations
  4. 4Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis2010 · 93 citations
  5. 5Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblast Leukemia: A Systematic Review2019 · 81 citations